查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1650908

全球血红素检测市场

Hemoglobin Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血红素检测市场规模将达到 39 亿美元

2024 年全球血红素检测市场规模估计为 28 亿美元，预计到 2030 年将达到 39 亿美元，2024-2030 年分析期间的复合年增长率为 5.6%。血红素检测试剂和耗材是报告中分析的细分市场之一，预计到分析期结束时复合年增长率为 5.8%，达到 30 亿美元。在分析期内，血红素检测设备部分预计将以 4.9% 的复合年增长率成长。

美国市场规模估计为 7.421 亿美元，中国市场预计复合年增长率为 8.2%

预计 2024 年美国血红素检测市场价值将达到 7.421 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 8.857 亿美元，2024-2030 年分析期间的复合年增长率为 8.2%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 2.8% 和 5.1%。在欧洲，德国的复合年增长率预计为 3.3%。

全球血红素检测市场 - 主要趋势和驱动因素摘要

血红素测试对于诊断血液疾病是否重要？

血红蛋白检测在现代医疗保健中发挥着至关重要的作用，为患者的血液健康和整体健康状况提供了重要的见解。但为什么这项测试不可或缺？血红蛋白是红血球中的一种蛋白质，它将氧气从肺部输送到全身。透过测量血液中的血红蛋白浓度，医疗保健提供者可以评估一个人的携氧能力并发现潜在的健康问题，例如贫血，出血或其他潜在疾病。血红素检测是常规检查、术前评估和慢性病管理最常用的诊断工具之一。

血红素水平是许多健康状况的重要指标。血红蛋白水平低通常表示患有贫血，即身体没有足够的健康红血球来有效地输送氧气。贫血可由多种因素引起，包括营养缺乏（如缺乏铁、维生素 B12 或叶酸）以及肾臟病或癌症等慢性疾病。相反，高血红蛋白水平可能表示存在红血球增多症和脱水等状况。因此，定期进行血红蛋白检测不仅对于诊断某些血液疾病至关重要，而且对于监测整体健康状况和指导慢性病患者的治疗计划也至关重要。

科技如何改变血红素测试？

技术进步彻底改变了血红素测试，使其更快、更准确、功能更多。最重要的技术创新之一是即时诊断（POCT）设备的开发，该设备可以在传统实验室之外、在医生办公室甚至在家中测量血红蛋白水平。这些可携式设备可提供近乎即时的结果，帮助医疗保健提供者快速做出诊断决策。这些即时资料对于管理贫血等病症以及在化疗和透析等治疗期间监测血液健康特别有用。

自动血液分析仪是血红素检测的另一项重大进展。这些设备只需几分钟就能高精度地处理多种血液参数，包括血红素浓度。这些设备整合的先进软体和演算法提高了诊断准确性，减少了人为错误，并提高了测试结果的整体可靠性。许多现代分析仪也采用了标记系统，可以提醒临床医生血红蛋白浓度异常或血液样本可能存在的问题，从而可以儘早准确地发现危急情况。

非侵入性血红素检测是另一项极具潜力的新兴技术。传统的血红蛋白测试需要用针或手指刺穿血液样本，这可能会给患者带来不舒服。然而，正在开发的新型光学和基于感测器的技术无需抽血即可测量血红蛋白浓度。该设备利用光学波长和脉搏血氧计技术，可透过皮肤估算血红素浓度，为持续监测提供无痛、便捷的选择，特别是在手术室和加护病房等环境中。这些技术进步使得血红素测试更加方便患者、更容易患者使用，同时保持了高水准的诊断准确性。

为什么血红素检测对健康管理很重要？

血红素检测对于健康管理极为重要。这是因为血红蛋白测试提供了有关您的身体输送氧气能力的重要信息，这项功能对您的整体健康和活力至关重要。对于患有贫血等疾病的人来说，定期进行血红素检测可以帮助监测病情的进展和治疗的效果。血红素水平低会导致疲劳、虚弱和呼吸急促等症状，严重影响生活品质。透过定期检测确定血红蛋白水平低的原因，可以帮助医疗保健提供者治疗潜在的问题，无论是营养缺乏、慢性疾病或其他疾病。

对于接受化疗和透析等某些治疗的患者，血红蛋白测试是管理护理的常规部分。例如，在癌症治疗中，化疗的副作用是引起贫血，导致血红素水平危险地低。定期监测可以让医疗保健提供者迅速采取输血或药物等治疗措施来促进红血球的生成。同样，患有慢性肾臟病的人经常会出现贫血，因为他们的肾臟无法产生足够的促红血球生成素（一种刺激红血球生成的荷尔蒙）。对这些患者进行血红蛋白测试可以帮助指导适当使用药物，如促红血球生成素刺激剂 (ESA) 和铁补充剂。

在手术中，手术前后的血红蛋白测试至关重要。术前血红素测试可确保患者有足够的红血球来承受手术压力，术后测试可监测任何出血或併发症的迹象。血红素水平在怀孕期间也很重要，因为贫血会对母亲和胎儿造成风险。定期产前检查可以帮助孕妇维持健康的血红素水平，并降低早产和低出生体重等併发症的风险。血红蛋白检测提供了关键资料，可在不同的医疗保健场景中支持更好的健康结果，并已成为管理急性和慢性疾病的重要工具。

哪些因素推动了血红素检测市场的成长？

血红蛋白检测市场的成长受到几个关键因素的推动，例如贫血和慢性病盛行率的上升、检测技术的进步以及对照护现场诊断的需求不断增加。其中一个主要驱动因素是全球范围内需要定期监测血红蛋白的疾病的增加，包括贫血、糖尿病、慢性肾臟病和癌症。根据世界卫生组织 (WHO) 的数据，光是贫血就影响全世界超过 16 亿人，需要频繁检测来控制这种普遍存在的疾病。随着世界人口老化和慢性病负担增加，对可靠、有效的血红素检测的需求也日益增加。

技术进步，尤其是即时诊断测试，是推动市场成长的另一个关键因素。照护现场血红素检测设备因其便利性、便携性和快速结果而越来越受临床和家庭环境的欢迎。这些设备可以即时监测血红蛋白水平，使医疗保健提供者能够做出更快、更明智的治疗决策。随着远端医疗和居家医疗变得越来越普遍，尤其是在 COVID-19 疫情的影响下，对 POC 血红蛋白测试等易于使用且易于获取的诊断工具的需求日益增加。

非侵入性血红素检测技术也促进了市场的扩张。虽然传统的血红蛋白测试需要采血，但使用基于光的技术来估计血红蛋白水平的非侵入性设备为患者提供了更舒适、更方便的选择。此类创新在小儿科、急诊和外科环境中尤其具有吸引力，因为减少不适和简化检查可以改善患者的体验和治疗结果。随着这些技术变得更加复杂和广泛采用，它们在血红蛋白检测市场中的份额预计会增加。

个人化医疗的需求不断增长也是推动血红素检测成长的因素之一。随着医疗保健逐渐转向基于个别患者资料的个人化治疗方案，频繁且准确地监测血红蛋白等关键生物标记至关重要。例如，接受化疗和透析等治疗的患者通常依赖即时血红素水平来个性化药物剂量和输血计划。这一趋势正在推动更复杂的血红蛋白检测解决方案的发展，这些解决方案可以快速有效地提供详细的患者特定资料。

最后，旨在消除贫血和其他血液疾病的政府措施和公共卫生宣传活动也在推动市场成长。在许多国家，贫血仍然是一个重大的公共卫生问题，尤其是对于孕妇和儿童。提高意识、提高诊断率和增加治疗机会的努力正在导致发达和发展中地区血红蛋白检测的使用范围扩大。随着世界各地的医疗保健系统注重提高诊断能力和更有效地管理慢性疾病，对可靠且可访问的血红蛋白检测的需求预计将持续增长，成为全球诊断市场的关键增长领域。

部分

组件（试剂、耗材、设备）；最终用途（医院、诊断实验室、其他最终用途）

受访公司范例（44家值得关注的公司）

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP12342

Global Hemoglobin Testing Market to Reach US$3.9 Billion by 2030

The global market for Hemoglobin Testing estimated at US$2.8 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Hemoglobin Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Hemoglobin Testing Equipment segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$742.1 Million While China is Forecast to Grow at 8.2% CAGR

The Hemoglobin Testing market in the U.S. is estimated at US$742.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$885.7 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Hemoglobin Testing Market - Key Trends and Drivers Summarized

Is Hemoglobin Testing the Cornerstone of Diagnosing Blood Disorders?

Hemoglobin testing plays a vital role in modern healthcare, offering key insights into a patient’s blood health and overall well-being. But why is this testing so essential? Hemoglobin is a protein in red blood cells that carries oxygen from the lungs to the rest of the body. By measuring the levels of hemoglobin in the blood, healthcare providers can assess a person’s oxygen-carrying capacity and detect potential health issues such as anemia, blood loss, or other underlying conditions. Hemoglobin testing is one of the most common diagnostic tools, used in routine checkups, pre-surgical evaluations, and managing chronic diseases.

Hemoglobin levels are critical indicators of various health conditions. Low hemoglobin levels often point to anemia, a condition in which the body doesn’t have enough healthy red blood cells to transport oxygen efficiently. Anemia can be caused by factors ranging from nutritional deficiencies (like iron, vitamin B12, or folate) to chronic diseases such as kidney disease or cancer. Conversely, high hemoglobin levels can indicate conditions such as polycythemia or dehydration. Regular hemoglobin testing is therefore essential not only for diagnosing specific blood disorders but also for monitoring overall health and guiding treatment plans for individuals with chronic conditions.

How Has Technology Transformed Hemoglobin Testing?

Technological advancements have revolutionized hemoglobin testing, making it faster, more accurate, and accessible in a variety of settings. One of the most significant innovations is the development of point-of-care testing (POCT) devices, which allow for hemoglobin levels to be measured outside of traditional laboratories, in clinics, or even at home. These portable devices provide nearly instant results, helping healthcare providers make quicker diagnostic decisions, especially in emergency or remote settings where access to full laboratory services might be limited. This real-time data is particularly valuable in managing conditions like anemia or monitoring blood health during treatments such as chemotherapy or dialysis.

Automated hematology analyzers represent another major advancement in hemoglobin testing. These machines can process multiple blood parameters, including hemoglobin concentration, in just a few minutes with high precision. The integration of advanced software and algorithms into these devices has enhanced their diagnostic accuracy, reducing human error and improving the overall reliability of test results. Many modern analyzers also incorporate flagging systems that alert clinicians to abnormal hemoglobin levels or potential issues with the blood sample, ensuring that critical conditions are detected early and accurately.

Non-invasive hemoglobin testing is another emerging technology that holds great promise. Traditional hemoglobin tests require a blood sample drawn through a needle or fingerstick, which can be uncomfortable for patients. However, new optical and sensor-based technologies are being developed to measure hemoglobin levels without the need for a blood sample. Devices using light wavelengths and pulse oximetry techniques can estimate hemoglobin levels through the skin, providing a painless, convenient option for continuous monitoring, particularly in settings such as operating rooms or intensive care units. These technological advancements are making hemoglobin testing more patient-friendly and accessible while maintaining high levels of diagnostic accuracy.

Why Is Hemoglobin Testing Critical for Managing Health?

Hemoglobin testing is crucial for managing health because it provides essential information about a person’s ability to transport oxygen throughout their body, a key function for overall health and vitality. For individuals with conditions like anemia, regular hemoglobin testing helps monitor disease progression and the effectiveness of treatments. Low hemoglobin levels can lead to fatigue, weakness, and shortness of breath, symptoms that can severely impact quality of life. Identifying the cause of low hemoglobin through routine testing allows healthcare providers to treat the underlying issue, whether it’s a nutritional deficiency, chronic disease, or another condition.

For patients undergoing certain treatments, such as chemotherapy or dialysis, hemoglobin testing is a routine part of managing care. In cancer treatment, for instance, chemotherapy can cause anemia as a side effect, leading to dangerously low hemoglobin levels. Regular monitoring ensures that healthcare providers can intervene promptly with treatments like blood transfusions or medication to boost red blood cell production. Similarly, patients with chronic kidney disease often experience anemia because their kidneys are not producing enough erythropoietin, a hormone that stimulates red blood cell production. Hemoglobin testing in these patients helps guide the appropriate use of medications like erythropoiesis-stimulating agents (ESAs) and iron supplements.

In surgical settings, hemoglobin testing is essential both before and after procedures. Pre-surgical hemoglobin testing ensures that a patient has sufficient red blood cells to withstand the stress of surgery, while post-surgical testing monitors for signs of blood loss or complications. Hemoglobin levels are also important in pregnancy, where anemia can pose risks to both the mother and baby. Regular testing during prenatal care helps ensure that pregnant women maintain healthy hemoglobin levels, reducing the risk of complications like preterm birth or low birth weight. Across these various healthcare scenarios, hemoglobin testing provides critical data that supports better health outcomes, making it an indispensable tool in managing both acute and chronic conditions.

What Factors Are Driving the Growth of the Hemoglobin Testing Market?

The growth of the hemoglobin testing market is driven by several key factors, including the rising prevalence of anemia and chronic diseases, advancements in testing technology, and increasing demand for point-of-care diagnostics. One of the primary drivers is the global rise in conditions like anemia, diabetes, chronic kidney disease, and cancer, which require regular hemoglobin monitoring. Anemia alone affects over 1.6 billion people worldwide, according to the World Health Organization (WHO), driving the need for frequent testing to manage this widespread condition. As the global population ages and the burden of chronic disease grows, the demand for reliable, efficient hemoglobin testing continues to increase.

Technological advancements, particularly in point-of-care testing, are another significant factor propelling market growth. Point-of-care hemoglobin testing devices are becoming more common in both clinical and home settings due to their convenience, portability, and rapid results. These devices allow for real-time monitoring of hemoglobin levels, helping healthcare providers make faster, more informed treatment decisions. As telemedicine and at-home healthcare gain traction, especially in light of the COVID-19 pandemic, the demand for easy-to-use, accessible diagnostic tools like point-of-care hemoglobin tests is on the rise.

Non-invasive hemoglobin testing technologies are also contributing to market expansion. While traditional hemoglobin testing requires blood samples, non-invasive devices that use light-based technologies to estimate hemoglobin levels offer a more comfortable and convenient option for patients. These innovations are particularly appealing in settings like pediatrics, emergency care, and surgical environments, where reducing discomfort and streamlining testing can lead to better patient experiences and outcomes. As these technologies become more refined and widely adopted, they are expected to capture a growing share of the hemoglobin testing market.

The rising demand for personalized medicine is another factor fueling the growth of hemoglobin testing. As healthcare moves towards more tailored treatment plans based on individual patient data, frequent and accurate monitoring of key biomarkers like hemoglobin is essential. For instance, in patients receiving treatments like chemotherapy or dialysis, personalized adjustments to medication dosages or transfusion schedules often depend on real-time hemoglobin levels. This trend is pushing the development of more sophisticated hemoglobin testing solutions that can deliver detailed, patient-specific data quickly and efficiently.

Lastly, government initiatives and public health campaigns aimed at combating anemia and other blood disorders are also driving market growth. In many countries, anemia remains a significant public health issue, particularly in pregnant women and children. Efforts to increase awareness, improve diagnosis rates, and enhance access to treatment are leading to greater utilization of hemoglobin testing in both developed and developing regions. As healthcare systems around the world focus on improving diagnostic capabilities and managing chronic diseases more effectively, the demand for reliable and accessible hemoglobin testing is expected to continue rising, making it a key growth area in the global diagnostics market.

SCOPE OF STUDY:

The report analyzes the Hemoglobin Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents & Consumables, Equipment); End-Use (Hospitals, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Hemoglobin Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Anemia and Blood Disorders Propels Demand for Hemoglobin Testing Solutions
    • Role of Hemoglobin Testing in Supporting Routine Health Checkups and Chronic Disease Management
    • Growth in Demand for Anemia Testing in Pregnant Women and Pediatric Populations Drives Adoption
    • Expansion of Hemoglobin Testing Solutions in Blood Banks and Transfusion Centers Fuels Market Growth
    • Growth in Demand for Hemoglobin A1c Testing for Diabetes Management Expands Addressable Market
    • Role of Hemoglobin Testing in Supporting Blood Donation and Safe Transfusion Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hemoglobin Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hemoglobin Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Hemoglobin Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hemoglobin Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Hemoglobin Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Hemoglobin Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Hemoglobin Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Hemoglobin Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Hemoglobin Testing by Component - Reagents & Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Hemoglobin Testing by Component - Reagents & Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Hemoglobin Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Hemoglobin Testing by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Hemoglobin Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION